SCHEMBL29062

SCHEMBL29062

O=C(O)CCc1ccccc1C(=O)O

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FOLH1 Q04609 2/20 0.66
KEAP1 Q14145 1/20 0.54
ALDH1A1 P00352 4/20 0.52
ALOX15 P16050 1/20 0.52
FFAR1 O14842 2/20 0.50
HPGD P15428 2/20 0.50
TSHR P16473 1/20 0.50
HSD17B10 Q99714 1/20 0.50
PTGER1 P34995 1/20 0.50
PTGER4 P35408 1/20 0.50
PTGER3 P43115 1/20 0.50
PTGER2 P43116 1/20 0.50
LMNA P02545 1/20 0.47
HMGB1 P09429 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.45
HDAC3 O15379 1/20 0.45
MAPK1 P28482 1/20 0.45
ADRA1A P35348 1/20 0.45
HDAC4 P56524 1/20 0.45
SLC6A3 Q01959 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acetonitrile SCHEMBL28166333 0.89 FOLH1 (0.54) FOLH1KEAP1ALDH1A1ALOX15FFAR1
SCHEMBL8696243 0.89 FOLH1 (0.53) FOLH1KEAP1ALDH1A1ALOX15FFAR1
SCHEMBL30637100 0.88 FOLH1 (0.61) FOLH1KEAP1ALDH1A1ALOX15FFAR1
SCHEMBL9759595 0.88 FOLH1 (0.61) FOLH1KEAP1ALDH1A1ALOX15FFAR1
SCHEMBL30365583 0.87 FOLH1 (0.76) FOLH1ALDH1A1ALOX15HPGDTSHR
SCHEMBL70392 0.87 FOLH1 (0.76) FOLH1ALDH1A1ALOX15HPGDTSHR
SCHEMBL27568253 0.86 FOLH1 (0.63) FOLH1ALDH1A1ALOX15HPGDTSHR
SCHEMBL503904 0.85 MAPT (0.59) FOLH1HDAC3HDAC4HDAC1HDAC7
SCHEMBL9861570 0.85 MAPT (0.59) FOLH1HDAC3HDAC4HDAC1HDAC7
SCHEMBL59198 0.84 KEAP1 (0.65) KEAP1FFAR1HSD17B10PTGER1PTGER4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 145 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117700845-A High-rebound resilience rubber ball for seed machine and preparation method thereof 河北橡一医药科技股份有限公司 2024-03-15 CN claimed
US-7732625-B2 Colorant compounds XEROX CORPORATION (US) 2010-06-08 US claimed
US-7311767-B2 Forming a salt of a liquid phase change ink carrier of stearyl stearamide, an amine substituted Xanthene, acridine, anthracene or thioxanthene chromogen, and a metal salt capable of forming a compound with two chromogens XEROX CORPORATION (US) 2007-12-25 US claimed
US-7033424-B2 Phase change inks XEROX CORPORATION (US) 2006-04-25 US claimed
US-20060021546-A1 Processes for preparing phase change inks XEROX CORPORATION 2006-02-02 US claimed
US-20060020141-A1 Metallized dye XEROX CORPORATION 2006-01-26 US claimed
US-20060016369-A1 PHASE CHANGE INKS XEROX CORPORATION 2006-01-26 US claimed
US-20060004123-A1 PHASE CHANGE INK PRINTING PROCESS XEROX CORPORATION 2006-01-05 US claimed
US-6946025-B2 Process for preparing tetra-amide compounds XEROX CORPORATION (US) 2005-09-20 US claimed
US-20050090690-A1 Process for preparing tetra-amide compounds XEROX CORPORATION 2005-04-28 US claimed
US-20260069740-A1 WOUND DRESSING MATERIAL AND METHODS OF MAKING AND USING THE SAME SOLVENTUM INTELLECTUAL PROPERTIES COMPANY (US) 2026-03-12 US disclosed
EP-4704830-A2 MRGPRX2 INHIBITORS AND METHODS OF USE THEREOF Septerna, Inc. (US) 2026-03-11 EP disclosed
US-20250326731-A1 CATALYST-CONTROLLED SITE-SELECTIVE METHYLENE C-H LACTONIZATION OF DICARBOXYLIC ACIDS SCRIPPS RESEARCH INST (US) 2025-10-23 US disclosed
US-12433794-B2 Wound dressing material and methods of making and using the same SOLVENTUM INTELLECTUAL PROPERTIES COMPANY (US) 2025-10-07 US disclosed
EP-4284314-B1 REINFORCED FIBER WEB AND WOUND DRESSING MATERIAL CONTAINING IT SOLVENTUM INTELLECTUAL PROPERTIES COMPANY (US) 2025-08-06 EP disclosed
US-4803225-A Dihydroxy-phenethylamino compounds useful as pharmaceuticals FISONS, PLC (GB) 1989-02-07 US disclosed
US-4720586-A Substituted 3,4-dihydroxy-phenylethylamino compounds FISONS, PLC (GB) 1988-01-19 US disclosed
EP-0142283-A2 Phenylethylamines, process for their preparation and compositions containing them FISONS plc (GB) 1985-05-22 EP disclosed
US-4024131-A ANTIINFLAMMATORY PLURICHEMIE ANSTALT (FL) 1977-05-17 US disclosed
US-4021408-A DYES, PESTICIDES, STABILIZERS FOR POLYMERS BASF AKTIENGESELLSCHAFT (DT) 1977-05-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250326731-A1 CATALYST-CONTROLLED SITE-SELECTIVE METHYLENE C-H LACTONIZATION OF DICARBOXYLIC ACIDS DNPH1, NISCH, PTMA FOLH1 150/4885KEAP1 3162/4885ALDH1A1 3847/4885
US-20060020141-A1 Metallized dye CDYL, CDY1; CDY1B, CDYL2 FOLH1 3917/4885KEAP1 1864/4885ALDH1A1 1569/4885
US-20050090690-A1 Process for preparing tetra-amide compounds TAF9, TAF5, TAF1 FOLH1 4875/4885KEAP1 2845/4885ALDH1A1 1723/4885
US-20260069740-A1 WOUND DRESSING MATERIAL AND METHODS OF MAKING AND USING THE SAME DSC1, SDC2, DSG1 FOLH1 3470/4885KEAP1 1580/4885ALDH1A1 1329/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.